Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow OMNICELL, INC.

Get SEC filing alerts via email and in your feed for OMNICELL, INC.

OMCL

OMNICELL, INC.

About OMNICELL, INC.

Omnicell designs and provides medication management automation, software workflows, and expert services for healthcare facilities. Its solutions enhance safety, efficiency, and patient adherence across inpatient, outpatient, and retail settings. Focused on the industry vision of the Autonomous Pharmacy, the company addresses challenges like labor shortages, medication errors, and rising drug costs, supporting healthcare providers worldwide with integrated, data-driven medication automation and optimization systems.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from OMNICELL, INC.

1
1
OMNICELL, INC. Omnicell Reports 15% Revenue Growth and Net Income Turnaround in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
OMNICELL, INC. Omnicell Reports $1.18 Billion Revenue for Fiscal Year 2025, Driven by Product and Service Growth

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
OMNICELL, INC. Omnicell Reports 10% Revenue Growth to $310.6 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
OMNICELL, INC. Omnicell Reports 5% Revenue Growth to $290.6 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
OMNICELL, INC. Omnicell Reports $269.7 Million Revenue in Q1 2025, 10% Year-Over-Year Growth

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
OMNICELL, INC. Omnicell Reports $1.11 Billion Revenue for Fiscal Year 2024, Net Income Recovery

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
OMNICELL, INC. Omnicell Reports Mixed Q3 2024 Financial Results with Decreased Revenues and Improved Net Income

Via official filing (AI summary) | over 1 year ago | 0 comments